These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 25421898)

  • 1. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
    Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
    J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications.
    Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A
    Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
    Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
    Barkat A; Beg S; Panda SK; S Alharbi K; Rahman M; Ahmed FJ
    Semin Cancer Biol; 2021 Feb; 69():365-375. PubMed ID: 31442571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
    Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart Mesoporous Silica Nanocarriers for Antitumoral Therapy.
    Baeza A; Vallet-Regí M
    Curr Top Med Chem; 2015; 15(22):2306-15. PubMed ID: 26043739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery.
    Salve R; Kumar P; Ngamcherdtrakul W; Gajbhiye V; Yantasee W
    Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112084. PubMed ID: 33947574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
    Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
    Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
    Qu Q; Ma X; Zhao Y
    Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles: a versatile carrier platform in lung cancer management.
    Dhingra S; Goyal S; Thirumal D; Sharma P; Kaur G; Mittal N
    Nanomedicine (Lond); 2024 Jun; 19(15):1331-1346. PubMed ID: 39105754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer.
    Castillo RR; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Feb; 14(2):229-243. PubMed ID: 27402029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.